Please login to the form below
opicapone
This page shows the latest opicapone news and features for those working in and with pharma, biotech and healthcare.
Neurocrine bags FDA approval for first tardive dyskinesia drug
The company fleshed out its movement disorder pipeline earlier this year by licensing opicapone from Portuguese drug maker BIAL.
Latest news
-
EC approves Bial’s Parkinson’s disease therapy
Manufactured by Bial, Ongentys (opicapone) is indicated as adjunctive therapy to preparations of levodopa/DOPA decarboxylase inhibitors (DDCIs) in adults with Parkinson's and end-of-dose motor fluctuations who cannot ... Opicapone is a third-generation
-
Chasing the cure for Parkinson's disease
Opicapone (Bial) is a COMT inhibitor in phase III development in various European countries for the treatment of idiopathic Parkinson's. ... Bial plans to develop opicapone to be administered in combination with levodopa/carbidopa or
More from news
Approximately 1 fully matching, plus 2 partially matching documents found.
Latest Intelligence
-
Deal Watch February 2017
Royalty monetisation. 150. BIAL/ Neurocrine Biosciences. ONGENTYS (opicapone), COMT inhibitor for Parkinson's disease (approved in EU).
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Featured jobs
- Head of Partnerships - Competitive - London
-
Competitive Salary Offered
- NEW FREELANCE OPPORTUNITIES!!! LONDON and HOME WORKING!
-
EXCELLENT DAY RATES AVAILABLE
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
-
Senior Medical Writer
-
Salary TBC
-
Midweight Brand Planner
-
Up to £50, 000
Subscribe to our email news alerts
- Health comms agency emotive hires new cell and gene therapy leader
- Success breeds success
- RNA-focused biotech Storm Therapeutics raises extra £14m
- Europe responding to gene therapy challenge, but picture remains fragmented
- Turning learning into action: The challenge of behaviour change
- Syncona launches another cell therapy company, Treg specialist Quell
PMHub
PRMA Consulting Ltd
PRMA Consulting is an independent consultancy solving some of the most challenging pricing, reimbursement and market access issues facing international...
Latest intelligence
- Success breeds success
- This week we received the exciting news that we have been shortlisted for the Times Business Awards 2019, Tunbridge Wells in the 'Best Business 1-25 Employees' category....
- Turning learning into action: The challenge of behaviour change
- ...
- Investing in our People
- As a small, boutique agency we can and do invest heavily in our team, who produce amazing results for our clients....
Quick links
Infographics
